The Safety and Efficacy Evaluation of CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Anti cd19 chimeric antigen receptor T cell therapy Innovative Cellular Therapeutics (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 14 Apr 2017 Status changed to recruiting.
- 08 Jul 2016 New trial record